Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Goodwill & Intangibles (2016 - 2025)

Haemonetics has reported Goodwill & Intangibles over the past 16 years, most recently at $1.0 billion for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 4.14% year-over-year to $1.0 billion; the TTM value through Dec 2025 reached $1.0 billion, down 4.14%, while the annual FY2025 figure was $1.1 billion, 9.14% up from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $1.0 billion at Haemonetics, down from $1.0 billion in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $1.1 billion in Q2 2024 and troughed at $715.9 million in Q3 2023.
  • A 5-year average of $895.7 million and a median of $826.0 million in 2021 define the central range for Goodwill & Intangibles.
  • Biggest five-year swings in Goodwill & Intangibles: skyrocketed 142.01% in 2021 and later dropped 6.54% in 2022.
  • Year by year, Goodwill & Intangibles stood at $805.8 million in 2021, then fell by 6.87% to $750.5 million in 2022, then surged by 31.15% to $984.3 million in 2023, then grew by 8.8% to $1.1 billion in 2024, then fell by 4.14% to $1.0 billion in 2025.
  • Business Quant data shows Goodwill & Intangibles for HAE at $1.0 billion in Q4 2025, $1.0 billion in Q3 2025, and $1.1 billion in Q2 2025.